TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/2/24 16:12 | 12/29/23 | ZIVO | Zivo Bioscience, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Maggiore Christopher D. | OH | DT | P | 205 | 1.30 | 0 | 158 | 88 | 337 | D | |||||||||||||||
12/14/23 15:45 | 12/13/23 | ZIVO | Zivo Bioscience, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Maggiore Christopher D. | OH | DT | P | 45 | 1.00 | 0 | 45 | 34 | 179 | D | |||||||||||||||
2/14/23 08:33 | 9/14/22 | ZIVO | Zivo Bioscience, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Maggiore Christopher D. | OH | D | P.a | 25 | 3.53 | 0 | 7 | 1 | 723 | D | |||||||||||||||
9/19/22 16:16 | 9/14/22 | ZIVO | Zivo Bioscience, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Maggiore Christopher D. | OH | DT | P | 25 | 3.53 | 0 | 7 | 1 | 810 | D | |||||||||||||||
2/16/22 06:02 | 2/9/22 | ZIVO | Zivo Bioscience, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Maggiore Christopher D. | OH | DT | P.m | 340 | 3.72 | 0 | 91 | 13 | 803 | D | |||||||||||||||
1/14/22 17:48 | 1/11/22 | ZIVO | Zivo Bioscience, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Maggiore Christopher D. | OH | DT | P | 20 | 2.64 | 0 | 8 | 1 | 712 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |